| Scientific Name | Pharmaceutical form | Strength Value |
|---|---|---|
Inactivated Avian Reovirus - 1133 Strain/Inactivated Avian Reovirus - 2408 Strain/ Inactivated Avian Reovirus - MSB Strain/ Inactivated Bursal Disease Virus - Variant E Strain/Inactivated Bursal Disease Virus - Standard Strain |
Emulsion for injection |
NLT10ˆ6.97- , NLT10ˆ7.21- , NLT10ˆ7.39- , NLT 10ˆ4.5- , NLT 10ˆ4.7- |
Inactivated Foot and Mouth Disease (FMD)- Serotype A/ Inactivated Foot and Mouth Disease (FMD)- Serotype O/ Inactivated Foot and Mouth Disease (FMD)- Serotype Asia1/Inactivated Foot and Mouth Disease (FMD)- Serotype Sat2 |
Suspension for injection |
NLT 6.0- , NLT 6.0- , NLT 6.0- , NLT 6.0- |
Avian infectious bronchitis virus Massachusetts type strain H120 |
Lyophilisate for suspension |
3.3 log 10log10 EID50/dose |
Inactivated Newcastle Disease virus Ulster 2C strain/ Inactivated Infectious Bursal Disease virus VNJO strain |
Emulsion for injection |
NLT 50- , NLT 5- |
Inactivated Newcastle Disease virus Ulster 2C strain/ Inactivated Infectious Bronchitis virus Mass 41 strain/ Inactivated Infectious Bursal Disease virus VNJO strain |
Emulsion for injection |
NLT 50- , NLT 80- , NLT 5- |
Inactivated Newcastle Disease virus Ulster 2C strain |
Emulsion for injection |
NLT 50- |
Live attenuated fowl pox virus DCEP25 strain |
Lyophilisate and solvent for suspension for injection |
NLT 3.0- |
Attenuated Infectious Bronchitis Coronavirus strain CR88121 |
Effervescent tablet |
NLT 4.0- |
Avian Encephalomyelitis Virus/ Fowl Pox Virus |
Lyophilisate and solvent for suspension for injection |
NLT 10ˆ2.7- , NLT 10ˆ2.2- |
Inactivated Mycoplasma agalactiae N84 strain/Inactivated Mycoplasma capricolum strain 27343/ Inactivated Mycoplasma mycoides subsp mycoides HH strain |
Suspension for injection |
1:20U , 1:20U , 1:20U |